Ultragenyx Makes Competing Bid for Gene Therapy Biotech Dimension Tx – Xconomy
Xconomy |
Ultragenyx Makes Competing Bid for Gene Therapy Biotech Dimension Tx
Xconomy Besides offering Dimension shareholders an immediate cash return, Ultragenyx says that it can also close the transaction more quickly than RegenxBio (NASDAQ: RGNX). The board of Ultragenyx has already approved the deal, which the company says it … Bidding war erupts over Dimension's gene therapy pipeline as … Ultragenyx Proposes to Acquire Dimension Therapeutics for $5.50 … Ultragenyx trying to snag Regenxbio's takeover target |
